Regulation of Bile Acid and Cholesterol Metabolism by PPARs

Bile acids are amphipathic molecules synthesized from cholesterol in the liver. Bile acid synthesis is a major pathway for hepatic cholesterol catabolism. Bile acid synthesis generates bile flow which is important for biliary secretion of free cholesterol, endogenous metabolites, and xenobiotics. Bi...

Full description

Bibliographic Details
Main Authors: Tiangang Li, John Y. L. Chiang
Format: Article
Language:English
Published: Hindawi Limited 2009-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2009/501739
id doaj-91d292c99afa4c43945c589a6d53bba3
record_format Article
spelling doaj-91d292c99afa4c43945c589a6d53bba32020-11-25T00:59:57ZengHindawi LimitedPPAR Research1687-47571687-47652009-01-01200910.1155/2009/501739501739Regulation of Bile Acid and Cholesterol Metabolism by PPARsTiangang Li0John Y. L. Chiang1Department of Integrative Medical Sciences, Northeastern Ohio Universities College of Medicine, Rootstown, OH 44272, USADepartment of Integrative Medical Sciences, Northeastern Ohio Universities College of Medicine, Rootstown, OH 44272, USABile acids are amphipathic molecules synthesized from cholesterol in the liver. Bile acid synthesis is a major pathway for hepatic cholesterol catabolism. Bile acid synthesis generates bile flow which is important for biliary secretion of free cholesterol, endogenous metabolites, and xenobiotics. Bile acids are biological detergents that facilitate intestinal absorption of lipids and fat-soluble vitamins. Recent studies suggest that bile acids are important metabolic regulators of lipid, glucose, and energy homeostasis. Agonists of peroxisome proliferator-activated receptors (PPARα, PPARγ, PPARδ) regulate lipoprotein metabolism, fatty acid oxidation, glucose homeostasis and inflammation, and therefore are used as anti-diabetic drugs for treatment of dyslipidemia and insulin insistence. Recent studies have shown that activation of PPARα alters bile acid synthesis, conjugation, and transport, and also cholesterol synthesis, absorption and reverse cholesterol transport. This review will focus on the roles of PPARs in the regulation of pathways in bile acid and cholesterol homeostasis, and the therapeutic implications of using PPAR agonists for the treatment of metabolic syndrome.http://dx.doi.org/10.1155/2009/501739
collection DOAJ
language English
format Article
sources DOAJ
author Tiangang Li
John Y. L. Chiang
spellingShingle Tiangang Li
John Y. L. Chiang
Regulation of Bile Acid and Cholesterol Metabolism by PPARs
PPAR Research
author_facet Tiangang Li
John Y. L. Chiang
author_sort Tiangang Li
title Regulation of Bile Acid and Cholesterol Metabolism by PPARs
title_short Regulation of Bile Acid and Cholesterol Metabolism by PPARs
title_full Regulation of Bile Acid and Cholesterol Metabolism by PPARs
title_fullStr Regulation of Bile Acid and Cholesterol Metabolism by PPARs
title_full_unstemmed Regulation of Bile Acid and Cholesterol Metabolism by PPARs
title_sort regulation of bile acid and cholesterol metabolism by ppars
publisher Hindawi Limited
series PPAR Research
issn 1687-4757
1687-4765
publishDate 2009-01-01
description Bile acids are amphipathic molecules synthesized from cholesterol in the liver. Bile acid synthesis is a major pathway for hepatic cholesterol catabolism. Bile acid synthesis generates bile flow which is important for biliary secretion of free cholesterol, endogenous metabolites, and xenobiotics. Bile acids are biological detergents that facilitate intestinal absorption of lipids and fat-soluble vitamins. Recent studies suggest that bile acids are important metabolic regulators of lipid, glucose, and energy homeostasis. Agonists of peroxisome proliferator-activated receptors (PPARα, PPARγ, PPARδ) regulate lipoprotein metabolism, fatty acid oxidation, glucose homeostasis and inflammation, and therefore are used as anti-diabetic drugs for treatment of dyslipidemia and insulin insistence. Recent studies have shown that activation of PPARα alters bile acid synthesis, conjugation, and transport, and also cholesterol synthesis, absorption and reverse cholesterol transport. This review will focus on the roles of PPARs in the regulation of pathways in bile acid and cholesterol homeostasis, and the therapeutic implications of using PPAR agonists for the treatment of metabolic syndrome.
url http://dx.doi.org/10.1155/2009/501739
work_keys_str_mv AT tiangangli regulationofbileacidandcholesterolmetabolismbyppars
AT johnylchiang regulationofbileacidandcholesterolmetabolismbyppars
_version_ 1725215157206908928